Cargando…

Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients

The methylation of O(6)-methylguanine DNA methyltransferase (MGMT) gene promoter is a key biological marker in clinical neuro-oncology. Nevertheless, there is no consensus concerning the best technique for its assessment. In a recent study comparing five methods to analyze MGMT status, we found that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quillien, Véronique, Lavenu, Audrey, Sanson, Marc, Legrain, Michèle, Dubus, Pierre, Karayan-Tapon, Lucie, Mosser, Jean, Ichimura, Koichi, Figarella-Branger, Dominique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2014
Materias:	Laboratory Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905192/ https://www.ncbi.nlm.nih.gov/pubmed/24420923 http://dx.doi.org/10.1007/s11060-013-1332-y

Ejemplares similares

Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trial
por: Quillien, Véronique, et al.
Publicado: (2016)

DGKI Methylation Status Modulates the Prognostic Value of MGMT in Glioblastoma Patients Treated with Combined Radio-Chemotherapy with Temozolomide
por: Etcheverry, Amandine, et al.
Publicado: (2014)

Dual MGMT inactivation by promoter hypermethylation and loss of the long arm of chromosome 10 in glioblastoma
por: Richard, Sophie, et al.
Publicado: (2020)

Combination chemotherapy versus temozolomide for patients with methylated MGMT (m-MGMT) glioblastoma: results of computational biological modeling to predict the magnitude of treatment benefit
por: Castro, Michael, et al.
Publicado: (2021)

The prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients’ survival: a meta-analysis
por: Zhao, Hailong, et al.
Publicado: (2016)

MGMT gene promoter methylation by pyrosequencing method correlates volumetric response and neurological status in IDH wild-type glioblastomas
por: Hosoya, Tomohiro, et al.
Publicado: (2022)

Combining MGMT promoter pyrosequencing and protein expression to optimize prognosis stratification in glioblastoma
por: Li, Mingxiao, et al.
Publicado: (2021)

An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients
por: Ducray, François, et al.
Publicado: (2010)

Prognostic Role of Methylation Status of the MGMT Promoter Determined Quantitatively by Pyrosequencing in Glioblastoma Patients
por: Kim, Dae Cheol, et al.
Publicado: (2016)

The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma
por: Villani, Veronica, et al.
Publicado: (2015)

Overview of Cellular Immunotherapy for Patients with Glioblastoma
por: Vauleon, Elodie, et al.
Publicado: (2010)

Pyrosequencing versus methylation-specific PCR for assessment of MGMT methylation in tumor and blood samples of glioblastoma patients
por: Estival, Anna, et al.
Publicado: (2019)

Clinical Neuropathology practice guide 5-2015: MGMT methylation pyrosequencing in glioblastoma: unresolved issues and open questions
por: Bienkowski, Michal, et al.
Publicado: (2015)

Mitochondrial DNA copy number as a prognostic marker is age-dependent in adult glioblastoma
por: Sourty, Baptiste, et al.
Publicado: (2022)

MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR
por: Håvik, Annette Bentsen, et al.
Publicado: (2012)

The proteomic response in glioblastoma in young patients
por: Deighton, Ruth F., et al.
Publicado: (2014)

Functional invadopodia formed in glioblastoma stem cells are important regulators of tumor angiogenesis
por: Petropoulos, Christos, et al.
Publicado: (2018)

O6-Methylguanine-Methyltransferase (MGMT) Promoter Methylation Status in Glioma Stem-Like Cells is Correlated to Temozolomide Sensitivity Under Differentiation-Promoting Conditions
por: Villalva, Claire, et al.
Publicado: (2012)

Interactions among mitochondrial proteins altered in glioblastoma
por: Deighton, Ruth F., et al.
Publicado: (2014)

Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide
por: Sun, Stella, et al.
Publicado: (2012)

Microenvironment involved in FPR1 expression by human glioblastomas
por: Boer, J. C., et al.
Publicado: (2015)

The effects of antiepileptic drugs on the growth of glioblastoma cell lines
por: Lee, Ching-Yi, et al.
Publicado: (2016)

Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses
por: Conroy, Siobhan, et al.
Publicado: (2016)

SETMAR isoforms in glioblastoma: A matter of protein stability
por: Dussaussois-Montagne, Audrey, et al.
Publicado: (2016)

Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach
por: Collet, Brigitte, et al.
Publicado: (2011)

The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma
por: Yue, Qi, et al.
Publicado: (2013)

Evaluation of potential circulating biomarkers for prediction of response to chemoradiation in patients with glioblastoma
por: van Linde, Myra E., et al.
Publicado: (2016)

Association between MGMT Enhancer Methylation and MGMT Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma
por: Zappe, Katja, et al.
Publicado: (2023)

miR-331-3p regulates expression of neuropilin-2 in glioblastoma
por: Epis, Michael R., et al.
Publicado: (2013)

Ecotropic viral integration site 1 regulates EGFR transcription in glioblastoma cells
por: Mizuguchi, Asako, et al.
Publicado: (2019)

Epigenetic preconditioning with decitabine sensitizes glioblastoma to temozolomide via induction of MLH1
por: Gallitto, Matthew, et al.
Publicado: (2020)

Single-cell analysis of 5-aminolevulinic acid intraoperative labeling specificity for glioblastoma
por: Liu, Zhouzerui, et al.
Publicado: (2023)

Investigating the Potential of Lipids for Use as Biomarkers for Glioblastoma via an Untargeted Lipidomics Approach
por: Soylemez, Burcak, et al.
Publicado: (2023)

Nerve Growth Factor Stimulates Glioblastoma Proliferation through Notch1 Receptor Signaling
por: Park, Jun Chul, et al.
Publicado: (2018)

Epithelial growth factor receptor expression influences 5-ALA induced glioblastoma fluorescence
por: Fontana, Andrea O., et al.
Publicado: (2017)

Rapamycin and hydroxychloroquine combination alters macrophage polarization and sensitizes glioblastoma to immune checkpoint inhibitors
por: Hsu, Sanford P. C., et al.
Publicado: (2020)

Clinical Neuropathology practice news 1-2014: Pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma
por: Preusser, Matthias, et al.
Publicado: (2014)

Clinical validation of a novel quantitative assay for the detection of MGMT methylation in glioblastoma patients
por: Rosas-Alonso, Rocio, et al.
Publicado: (2021)

Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease
por: Mallawaaratchy, Duthika M., et al.
Publicado: (2016)

Immune genes are associated with human glioblastoma pathology and patient survival
por: Vauléon, Elodie, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_29vve7pmthm34qtoifbvker5ac